Innovating Works
halt-RONIN: Discovering chronic inflammation biomarkers that define key stages in the Healthy to NASH non alcoh... Servicio Cántabro de Salud participó en un HORIZON EUROPE HORIZON-HLTH-2022-STAYHLTH-02 Non-alcoholic fatty liver disease (NAFLD) is a multifactorial chronic inflammatory disease that is prevalent in 1 of 4 individuals with a si...
2022-11-22 - 2026-11-30 | Financiado
TIMELY: A patient centered early risk prediction prevention and intervention platform to support the conti... Servicio Cántabro de Salud participó en un H2020 H2020-SC1-DTH-2018-2020 Coronary artery disease (CAD) remains the leading cause of disease burden globally. CAD develops slowly, usually over decades, and depends o...
2020-12-08 - 2025-03-31 | Financiado
PRECISESADS: Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases Servicio Cántabro de Salud participó en un FP6 We concur to the IMI on Reclassification of SLE, connective tissue diseases and RA” call by presenting a proposal aimed at using the power o...
2014-02-01 - 2019-01-31 | Financiado
NUTRIMENTHE: Effect of diet on the mental performance of children Servicio Cántabro de Salud participó en un FP7 Current evidence on the effect of diet on mental performance (MP) is largely based on animal, retrospective studies, and short-term nutritio...
Financiado
PRECISESADS: Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases Servicio Cántabro de Salud participó en un FP7 We concur to the IMI on Reclassification of SLE, connective tissue diseases and RA call by presenting a proposal aimed at using the power of...
Financiado
PSYSCAN: Translating neuroimaging findings from research into clinical practice Servicio Cántabro de Salud participó en un FP7 Abstract 9 Neuroimaging (NI) has enormous potential to improve the clinical care of patients with psychiatric disorders, but has yet to deli...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.